About Delfina
Delfina is a maternal health technology company addressing the maternal health crisis in the United States through its integrated pregnancy data platform, Delfina Care. The company delivers personalized pregnancy care based on deep insights into each member's needs, combining AI-driven risk identification with high-touch, culturally competent support. Delfina's platform enables care teams to automate routine tasks and activate proactive care pathways to prevent complications, while pregnant members receive access to education, continuous doula support, telehealth services, and at-home monitoring through an engaging mobile app. The company serves healthcare providers, health plans, and employers nationwide, offering equitable access to pregnancy care across diverse populations. Delfina's high-risk care pathways are designed to reduce complications in pregnancy and birth, with the company guaranteeing same-year minimum ROI for health plan partners. The platform provides data for quality improvement reporting including HEDIS, NCQA, and CMS measures, and has achieved an 83.3 NPS score with a 5-star app store rating. Founded by doctors for doctors, Delfina partners with organizations including the National Association of Community Health Centers (NACHC) and Mayo Clinic to expand access to proactive maternal health support, particularly for communities facing the greatest barriers to healthcare access.
Mission & Story
Mission
Delfina is solving the maternal health crisis. Delfina Care helps bridge the maternal health gap by standardizing access to quality care to enable better outcomes for families and lower costs for payors.
Founding Story
Founded by doctors for doctors, with leadership including physician-founders with MD, PhD backgrounds
Clinical Focus
Medical conditions and clinical areas addressed by Delfina.
Who It Serves
Milestones & Awards
Recent Milestones
Selected for inaugural NACHC Accelerator 2026 cohort (March 2026). Partnership with Mayo Clinic announced for personalized metabolic health program. Transforming pregnancy care in California initiative. Partnership with NACHC to support community clinics across the country.
Awards & Recognition
Selected for NACHC Accelerator 2026 cohort as one of six innovative companies advancing health technology solutions for Community Health Centers
Key Partnerships
Company Details
- Headquarters
- San Francisco, CA, USA
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.